March 6, 2020

Study enrolling hospitalized adults with COVID-19 in Nebraska A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center (UNMC) in Omaha. The trial regulatory sponsor is the National Institute of Allergy and...

There are stark differences in prostate cancer incidence and mortality rate among certain races, primarily between the African-Americans and their European-American counterparts. While the latter has mostly been attributed to lower socioeconomic positions; access to health care, racial and ethnic discrimination, language and cultural barriers and delayed disease diagnosis in these populations, the former has...